News

RCS' Medical Procurement Organization; Strategy for Sustained Supply of Medicine and Medical Equipment Based on Transparency and Trust-Building

RCS' Medical Procurement Organization; Strategy for Sustained Supply of Medicine and Medical Equipment Based on Transparency and Trust-Building
The Medical Procurement Organization of the Red Crescent Society, utilizing a comprehensive network of production, supply, and distribution and with the aim of safeguarding public health and fulfilling its humanitarian mission, has formulated and implemented special macro and operational strategies to prevent any disruption in the supply chain of rare medicines and medical necessities.

According to the report by the Public Relations and International Affairs Unit of the Medical Procurement Organization, this organization, as the executive arm of the health system and strategic partner of the Ministry of Health, Treatment, and Medical Education, in the current conditions of the country, relying on its operational capacities and in line with fulfilling its governance role in the supply and distribution of special and single-prescription medicines, has employed all its capabilities for the uninterrupted continuity of the service delivery chain. In this framework, the continuous and sustainable supply of medicine and the development of the portfolio of pharmaceutical products and medical necessities is pursued as one of the strategic priorities of this entity, and optimal resource management and effective interaction with specialized institutions have provided the ground for desirable responsiveness to patients' needs in sensitive conditions.

 The Medical Procurement Organization, having five subsidiary companies and benefiting from two specialized pharmacies, has prioritized synergy between production and distribution sectors in its programs. In this regard, the organization's macro policies are designed in specialized platforms and think tanks so that, while continuously monitoring the market and precisely tracking medicine reserves in the "Situation Room," any pharmaceutical need is identified in the shortest possible time and the path for its supply is paved. Holding meetings of the Council of Managers to align the policies of subsidiary companies and forming specialized committees with international and domestic suppliers is also carried out with the aim of promoting financial transparency and accelerating bilateral cooperation processes. Additionally, the formation of crisis management and receivables collection committees has provided a platform for decisions to be made quickly, coordinately, and based on existing realities in sensitive conditions.

In the area of supply, the implementation of aggregate purchasing policies and targeted negotiations with suppliers and distribution companies has yielded significant achievements. These measures, in addition to reducing finished costs and improving pharmacy productivity, have helped optimize health system costs and strengthened the organization's financial sustainability. Improving supply processes and re-engineering the supply chain has also been implemented with the aim of reducing risks and guaranteeing patients' access to vital medicines, and extensive cooperation with the Food and Drug Organization has strengthened the supply network and facilitated the development of the product portfolio. In this path, specialized units such as the Commercial Affairs Department have also played their complementary role in achieving the organization's macro objectives.

The Medical Procurement Organization, using the capacity of single-prescription and emergency importing companies, through order in processes, timely payment, and accountability, has been able to be a credible and reliable brand for importers; both financially and in the sense that medicine reaches the actual consumer on time and through the legal channel. This organization, with transparent performance, has been able to be the executive arm and trustee of the Food and Drug Organization in normal and crisis conditions and is pursuing the development of the pharmaceutical portfolio by obtaining the necessary permits from the Food and Drug Organization.

 This organization, focusing on economic management, pharmaceutical portfolio development, and direct support for patients, has taken effective steps toward improving pharmaceutical services, ensuring financial sustainability, and increasing operational efficiency. The totality of these measures, carried out within the framework of the humanitarian objectives of the Red Crescent Society and in interaction with the Ministry of Health and other relevant institutions, has made a significant contribution to the strength of the country's health system and the reduction of patients' concerns. This operational approach is pursued with the aim of creating peace of mind for patients and reducing concerns related to the supply of vital medicines and medical equipment across the country, and its continuation at various levels of the organization, subsidiary companies, and specialized pharmacies is on the agenda.

Oct 25, 2026 09:25

Comments

Sender name is required
Email is required
Characters left: 500
Comment is required

Contact Us

Address : 52KM TEHRAN-QAZVIN HIGHWAY NEAR TO KORDAN BRIDGE KARAJ-IRAN

Phone : +98(26)34996855-8

Fax :+98(26)34996840 - +98(26)34996850

Email : info@soha1.ir

ZIP CODE : 33651-66596

 


نقشه